knowcompoundsvitamin D2
Specimen compound organic compoundPlate I
Vitamin D2

- Formula
- C28H44O
- Molar mass
- 396.659 g/mol
- ChEBI
- CHEBI:28934
- PubChem CID
- 5280793
- InChIKey
- MECHNRXZTMCUDQ-RKHKHRCZSA-N
↓ lowered 2 findings in 2 endpoints · – no difference found 4 in 4
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 4
- Limited
- 1
- Very limited
- 1
- Insufficient
- 0
Vitamin D2
Most findings
- Total cholesterol (TC)×2
- All-cause mortality×1
- C-reactive protein concentration×1
- HDL cholesterol×1
- LDL cholesterol×1
2 reference statements, not drawn · 36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Total cholesterol (TC)contested
- C-reactive protein concentration
- HDL cholesterol
- LDL cholesterol
- All-cause mortality
02 · contested · 1 endpoint
Where the findings disagree
012 findings
Total cholesterol (TC)
03 · findings
What vitamin D2 moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
6 shown
- LDL cholesterolMoved: no difference foundEvidence: ModeratePaper: PMID 417318032026
- Who
- Adults with obesity and/or metabolic syndrome; pooled randomised trials of vitamin D2 supplementation (about 1000 to 2000 IU/day, 6 to 12 months) versus placebo or no intervention
- Dose studied
- vitamin D2 1000 to 2000 IU/day across included trials (Table 1)
In contrast, the effects of vitamin D2 on total cholesterol and LDL were not significant.”
Quoted verbatim from Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis.meta-analysisPermalink - Total cholesterol (TC)contestedMoved: no difference foundEvidence: ModeratePaper: PMID 417318032026
- Who
- Adults with obesity and/or metabolic syndrome; pooled randomised trials of vitamin D2 supplementation (about 1000 to 2000 IU/day, 6 to 12 months) versus placebo or no intervention
- Dose studied
- vitamin D2 1000 to 2000 IU/day across included trials (Table 1)
In contrast, the effects of vitamin D2 on total cholesterol and LDL were not significant.”
Quoted verbatim from Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis.meta-analysisPermalink - C-reactive protein concentrationMoved: no difference foundEvidence: ModeratePaper: PMID 267001092016Industry funded
- Who
- Adults aged 30-75 at elevated risk of type 2 diabetes (non-diabetic hyperglycaemia or positive diabetes risk score), UK; vitamin D2 arm versus placebo arm
- Dose studied
- 100,000 IU ergocalciferol (vitamin D2) orally once monthly for 4 months
Among the secondary outcomes, there were no differences comparing D2 with placebo or D3 with placebo for anthropometric measures, blood pressure, hsCRP, CVD risk, assessed by UKPDS risk engine, hepatic markers, or fructosamine.”
Quoted verbatim from Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.RCT · 4 monthsPermalink - HDL cholesterolMoved: lowersEvidence: ModeratePaper: PMID 267001092016Industry funded
- Who
- Adults aged 30-75 at elevated risk of type 2 diabetes (non-diabetic hyperglycaemia or positive diabetes risk score), UK; vitamin D2 arm versus placebo arm
- Dose studied
- 100,000 IU ergocalciferol (vitamin D2) orally once monthly for 4 months
In the D2 group there were small, but statistically significant, decreases from baseline relative to placebo in total cholesterol and ApoB (favouring D2), as well as in HDL cholesterol and ApoA1 (favouring placebo; Figure 4A).”
Quoted verbatim from Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.RCT · 4 monthsPermalink - Total cholesterol (TC)contestedMoved: lowersEvidence: LimitedPaper: PMID 267001092016Industry funded
- Who
- Adults aged 30-75 at elevated risk of type 2 diabetes (non-diabetic hyperglycaemia or positive diabetes risk score), UK; vitamin D2 arm versus placebo arm
- Dose studied
- 100,000 IU ergocalciferol (vitamin D2) orally once monthly for 4 months
In the D2 group there were small, but statistically significant, decreases from baseline relative to placebo in total cholesterol and ApoB (favouring D2), as well as in HDL cholesterol and ApoA1 (favouring placebo; Figure 4A).”
Quoted verbatim from Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.RCT · 4 monthsPermalink - All-cause mortalityMoved: no difference foundEvidence: Very limitedPaper: PMID 244145522014
- Who
- Adults, healthy or in a stable phase of disease, in pooled randomised trials of vitamin D2 versus placebo or no intervention
- Dose studied
- not reported
Vitamin D2, alfacalcidol and calcitriol did not significantly affect mortality.”
Quoted verbatim from Vitamin D supplementation for prevention of mortality in adults.meta-analysisPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
04 · identity
Structure
- Charge
- 0
- SMILES
- [H][C@@]12CC[C@]([H])([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CCC/C2=CC=C1C[C@@H](O)CCC1=C
What the reference databases state
2Reference statements
What the reference databases state
Evidence keyStatements
2 statements
vitamin D2 is metabolised by each · Sources: Human-GEM, Rhea
- ProteinHuman-GEM MAR07996Inferred only
- ProteinRhea RHEA:46580Inferred only
6Reactions
07 · on the label · 665 products
Labelled products
Source: NIH DSLD · Ingredient: vitamin D2 · 665 products · Declared amount per serving: 40–5,000 IU
654 labels state an amount11 do not
- 365 Everyday ValueKid's Gummy Swirl Calcium + D Ergocalciferol200 IUper 1 Gummy(ies)DSLD:273924
- AbbottOptimin200 IU · 400 IUper 1 lozengeDSLD:211374
- AltrumEssential MultiVitamin D, as Ergocalciferol, 400 I.U.10 µgper 1 vegetarian capsuleDSLD:232380
- Amazing HerbsMultiVegErgocalciferol10 µgper 3 tabletsDSLD:272990
- Amazon ElementsAdult One DailyVitamin D2, from cultured Yeast, Ergocalciferol500 IUper 1 tabletDSLD:203783
- Amazon ElementsMen's 40+ One DailyVitamin D2, from cultured Yeast, Ergocalciferol1,000 IUper 1 tabletDSLD:203827
- Amazon ElementsVitamin D2 2000 IUVitamin D2, from cultured Yeast, Ergocalciferol2,000 IUper 1 capsuleDSLD:173066
- Amazon ElementsVitamin D2 50 mcgVitamin D2, from cultured Yeast, Ergocalciferol50 µgper 1 capsuleDSLD:270452
- American HealthMore Than A Greens Nutritional Powder With Advanced ProbioticsVitamin D, as Ergocalciferol400 IUper 9 gDSLD:65822
- AmvilabOrganic Multivitamin Gummy for Children 2+Ergocalciferol10 µgper 1 Gummy(ies)DSLD:298163
- AN Amazing Nutrition Amazing FormulasChildren's Chewable MultivitaminVitamin D, as Ergocalciferol400 IU · 200 IUper 1 tabletDSLD:251720
- AN Amazing Nutrition Amazing FormulasPrenatal One MultipleErgocalciferol400 IUper 1 tabletDSLD:251650
Show the remaining 653Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
08 · the record
Sources
237
papers screened for vitamin D2
- admitted
- 3
- read and discarded
- 168
- not read yet
- 66
Sources cited
3 papers · 6 findings